Literature DB >> 11908866

Histone deacetylase inhibitors such as sodium butyrate and trichostatin A induce apoptosis through an increase of the bcl-2-related protein Bad.

H Sawa1, H Murakami, Y Ohshima, T Sugino, T Nakajyo, T Kisanuki, Y Tamura, A Satone, W Ide, I Hashimoto, H Kamada.   

Abstract

The effects of sodium butyrate (SB) and trichostatin A (TSA) on cell proliferation andapoptosis against human glioma T98G, U251MG, and U877MG cells were investigated. Upon exposure to either SB or TSA, cell proliferation was reduced, and apoptosis detected by DNA fragmentation analysis and the cleavage of CPP32 was induced. Previously, we reported that SB increased the expression levels of p21 (WAF-1) and inhibited G1-S transition of the cell cycle. In this study, we showed that TSA also increased p21 expression, suggesting that histone deacetylase (HDAC) inhibitors may up-regulate p21 protein in common and thus arrest proliferation in the G1 phase of the cell cycle. To further determine the underlying molecular mechanisms of apoptosis with either SB or TSA treatment, we studied the expression levels of apoptosis-related proteins in human glioma cells. SB increased the expression of the Bad protein, although the expression of Bcl-2, Bcl-xL, Bax, and Fas was not changed by theaddition of SB. TSA treatment also up-regulated the expression of Bad protein. The results suggest that HDAC inhibitors such as SB and TSA induce apoptosis through an increase in Bad protein in human glioma cells in vitro.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11908866     DOI: 10.1007/bf02479423

Source DB:  PubMed          Journal:  Brain Tumor Pathol        ISSN: 1433-7398            Impact factor:   3.298


  21 in total

Review 1.  Mechanisms and clinical significance of histone deacetylase inhibitors: epigenetic glioblastoma therapy.

Authors:  Philip Lee; Ben Murphy; Rickey Miller; Vivek Menon; Naren L Banik; Pierre Giglio; Scott M Lindhorst; Abhay K Varma; William A Vandergrift; Sunil J Patel; Arabinda Das
Journal:  Anticancer Res       Date:  2015-02       Impact factor: 2.480

2.  Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas.

Authors:  Hong Duan; Caroline A Heckman; Linda M Boxer
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

3.  Therapy of thyroid carcinoma with the histone deacetylase inhibitor MS-275.

Authors:  Annette Altmann; Michael Eisenhut; Ulrike Bauder-Wüst; Annette Markert; Vasileios Askoxylakis; Holger Hess-Stumpp; Uwe Haberkorn
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-08-03       Impact factor: 9.236

4.  Trichostatin A enhances the response of chemotherapeutic agents in inhibiting pancreatic cancer cell proliferation.

Authors:  Paolo Piacentini; Massimo Donadelli; Chiara Costanzo; Patrick S Moore; Marta Palmieri; Aldo Scarpa
Journal:  Virchows Arch       Date:  2006-03-28       Impact factor: 4.064

5.  The calcium-binding protein S100B down-regulates p53 and apoptosis in malignant melanoma.

Authors:  Jing Lin; Qingyuan Yang; Paul T Wilder; France Carrier; David J Weber
Journal:  J Biol Chem       Date:  2010-06-29       Impact factor: 5.157

6.  The targeting of primary effusion lymphoma cells for apoptosis by inducing lytic replication of human herpesvirus 8 while blocking virus production.

Authors:  Carmen M Klass; Laurie T Krug; Veronika P Pozharskaya; Margaret K Offermann
Journal:  Blood       Date:  2005-02-01       Impact factor: 22.113

7.  Inhibition of histone deacetylases sensitizes glioblastoma cells to lomustine.

Authors:  Mikkel Staberg; Signe Regner Michaelsen; Rikke Darling Rasmussen; Mette Villingshøj; Hans Skovgaard Poulsen; Petra Hamerlik
Journal:  Cell Oncol (Dordr)       Date:  2016-10-20       Impact factor: 6.730

8.  Promoter- and cell-specific epigenetic regulation of CD44, Cyclin D2, GLIPR1 and PTEN by methyl-CpG binding proteins and histone modifications.

Authors:  Imke Müller; Frank Wischnewski; Klaus Pantel; Heidi Schwarzenbach
Journal:  BMC Cancer       Date:  2010-06-17       Impact factor: 4.430

9.  Histone deacetylase inhibitor MS-275 alone or combined with bortezomib or sorafenib exhibits strong antiproliferative action in human cholangiocarcinoma cells.

Authors:  Viola Baradari; Michael Höpfner; Alexander Huether; Detlef Schuppan; Hans Scherübl
Journal:  World J Gastroenterol       Date:  2007-09-07       Impact factor: 5.742

10.  Trichostatin A sensitizes cisplatin-resistant A549 cells to apoptosis by up-regulating death-associated protein kinase.

Authors:  Jun Wu; Cheng-ping Hu; Qi-hua Gu; Ye-peng Li; Min Song
Journal:  Acta Pharmacol Sin       Date:  2010-01       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.